Juli Mansnérus
Partner
Head of Patents & Life Sciences
The people I have worked with are extremely talented in communication & teams’ skills and deliver every time over the expected outcomes. They are innovative, understand the phenomena around us and the different factors that influence in their work and the work they do with us. I give specific thanks for Juli Mansnérus in working with me.
– The Legal 500 EMEA 2022, TMT
Juli Mansnérus is able to combine her academic background with business acumen.
– The Legal 500 EMEA 2022, TMT
Service areas
Dr. Juli Mansnérus, Head of Patents and Life Sciences, is admitted to the Finnish Bar and holds both Swedish and Finnish law degrees. She earned a Doctor of Laws degree with a focus on intellectual property and pharmaceutical law, establishing herself as a key advisor in pan-European litigation for pharmaceuticals, medical devices, and other technology-driven industries.
Her practice encompasses both contentious and non-contentious matters, guiding clients in regulatory and strategic challenges from R&D and commercialization to market access and pharmaceutical marketing. Her Master of Sciences in Translational Medicine from the University of Edinburgh gives her an invaluable perspective on the evolving needs of life sciences, pharmaceutical, and health technology companies.
Dr. Mansnérus has served as Vice Chairman of the Finnish Copyright Council and is an alumna of Young Academy Finland. She continues to conduct post-doctoral research and teach various law courses at the University of Helsinki. With her unique combination of legal acumen and scientific insight, she provides comprehensive guidance for clients seeking success in a rapidly changing marketplace.
Dittmar & Indrenius Attorneys Ltd. (2021–present)
Hannes Snellman Attorneys Ltd. (2008–2021)
Skandinaviska Enskilda Banken AB (publ) (2004-2008)
University of Helsinki, Doctor of Laws (2016)
Harvard University, Visiting Researcher (2015)
University of Edinburgh, MSc. in Translational Medicine with Distinction (2014)
Hanken School of Economics, MSc. in Economics and Business Administration (Intellectual Property Law, 2010)
University of Stockholm, LL.M., MSc. in Economics and Business Administration (2008)
University of Stockholm, MSc. in Economics and Business Administration (2008)
- Finnish Bar Association
- Finnish Bar Association, Secretary of the Bar Exam Committee 2013–
- Finnish Bar Association’s Technology, communication and data protection expert group member 2018–2020
- Board Member of Ronald McDonald lastentalosäätiö sr, 2021–
- Member of Young Academy Finland, 2019–2023
- Vice Chairman of the Copyright Council 2020–2025
“Striking the Balance: Genomic Data, Consent and Altruism in the European Health Data Space in The European Health Data Space Examining a New Era in Data Protection. El Asry, E., Mansnérus,J. and Liede, S. In Slokenberga,S., Ó Cathaoir, K., Shabani M. 26 s. “
–Routledge (in print, 2025)
”Itsemääräämisoikeus ja innovatiiviset terapiat – kuka määrää? (in English:Self-determination rights and innovative therapies – who decides?) Blick, A., Mansnérus, J.”
– Defensor Legis 2/2025, (accepted, 2025)
“Lääkevalmisteiden off-label markkinnointi: tasapainoilua sananvapauden ytimen ulkorajoilla. (in English: “Off-label marketing of medicinal products: balancing on the outer edges of the core of freedom of speech” )8.2024 Díaz Hernández, M., Mansnérus, J., p. 39-66”
– Forum Iuris 2024
“Immateriaalioikeus (in English: “Intellectual Property Law”) Pihlajarinne T., Alén A., & Mansnérus J. In: Airaksinen, M., Alén, A., Bärlund, J. C., Jauhiainen, J., Kaisanlahti, T., Kanerva, J., Knuts, M., Kuoppamäki, P., Kymäläinen, S., Mansnérus, J., Mähönen, J. T., Pihlajarinne, T., Raitio, J., Viitanen, K. M., Villa, S.”
– Yritysoikeus, Alma Insights 2024
“Paving the Path for Sustainable and Responsible Off-Label Use of Pharmaceutical Products in Europe. Díaz Hernández, M., Roslin, W. F. O., Mansnérus, J., 2024, p. 129-152”
– European Journal of Health Law 31(2)2024
“Lääkkeiden off label -käyttö lapsipotilailla: lapsen osallisuuden oikeudelliset reunaehdot (in English: “Off-label use of medications in pediatric patients: the legal boundaries of child participation”) Mansnérus, J., Bonsdorff, C., Vornanen, P., p. 190-203 “
– Terveys ja lapsen oikeudet 2023
From the integrity of potency assays to safe clinical intervention: Legal perspectives. Roslin, W. F. O., Mansnérus, J., p. 151-163
– Potency Assays for Advanced Stem Cell Therapy Medicinal Products, Springer 2023
“Tekoälyn käyttömahdollisuudet julkisella sektorilla: Oikeudelliset reunaehdot ja kansainvälinen vertailu (in English: “Potential Uses of Artificial Intelligence in the Public Sector: Legal Boundaries and International Comparison”) Paasikivi, O., Tuohino, J. K., Mansnérus, J. & Lång, J., 31 Mar 2022, 66 p. (Sitran selvityksiä; no. 206)”
– Helsinki, Sitra 2022
“Vacunación: análisis jurídico comparado durante la pandemia de COVID-19 y a la luz de la jurisprudencia reciente ((in English: “Vaccination: A Comparative Legal Analysis During the COVID-19 Pandemic in Light of Recent Case Law” ) Wierzba, S., Mansnérus, J. & Malminen, T. Derecho de Familia 102, p. 6-12.”
– Derecho de Familia 2021
“Introduction Mansnerus, J., Lahti, R. & Blick, A. A., 2020, Personalized Medicine : Legal and Ethical Challenges. Mansnerus, J., Lahti, R. & Blick, A. (eds.). Helsinki: University of Helsinki, Faculty of Law, p. 1-3.”
– Forum Iuris 2020
“Over Ten Years Since the Adoption of the EU Regulation on Advanced Therapy Medical Products – Lessons Learned Thus Far. Mansnerus, J., 2020, Personalized Medicine: Legal and Ethical Challenges. Mansnerus, J., Lahti, R. & Blick, A. (eds.). Helsinki: University of Helsinki, Faculty of Law, p. 145-161.”
– Forum Iuris 2020
“Transatlantic Comparative Perspectives on Patenting Genome-editing Technologies: A Case Study of Patents on CRISPR/Cas9 Technology. Mansnerus, J. & Vaaraniemi, L., 2020, Personalized Medicine: Legal and Ethical Challenges. Mansnerus, J., Lahti, R. & Blick, A. (eds.). Helsinki: University of Helsinki, Faculty of Law, p. 187-214.”
– Forum Iuris 2020
“Vacunación: hacia un equilibrio entre libertad de conciencia e interés público: Análisis jurídico comparado durante la crisis del Covid-19 (In English: Vaccination: Towards a balance between freedom of conscience and public interest: Comparative legal analysis during the Covid-19 crisis). Wierzba, S. E., Mansnerus, J. & Malminen, T., Dec 2020, In: La Ley. 2020, 297, p. 1-6.”
– La Ley, 2020
“Forms and levels of legal protection of the human embryo in biomedical research in Finland and France Mansnerus, J., Dujardin, C. & Lahti, R., 2019, Guzik-Makaruk, E. M. & Plywaczewski, E. W. (eds.). Warszawa: Wydawnictwo C.H. Beck, p. 199–224 26 p. (Monografie Obcojęzyczne; vol. 8).”
– Current Problems of the Penal Law and Criminology: Aktuelle Probleme des Strafrechts und der Kriminologie 2019
“Bioethical and legal perspectives on cell reprogramming technologies. Mansnérus, J. A., p. 206-228.”
– Medical Law International 2016.
“Commercialisation of advanced therapies: a study of the EU regulation on advanced therapy medical products Mansnerus, J. A., Helsinki: University of Helsinki.”
– University of Helsinki 2016
“Brüstle v. Greenpeace: Implications for commercialisation of translational stem cell research Mansnérus, J., 22, 2, p. 141-164.”
– European Journal of Health Law 2/2015
“Encountering Challenges with the EU Regulation on Advance Therapy Medical Products Mansnérus, J., 2015, In: European Journal of Health Law. 22, p. 426-461.”
– European Journal of Health Law 5/2015
“Patentability of parthenogenic stem cells: International Stem Cell Corporation v. Comptroller General of Patents Mansnérus, J., 2015, In: European Journal of Health Law. 22, 3, p. 267-286.”
– European Journal of Health Law 3/2015
“Patentering av pluripotenta stamceller efter EU-domstolens dom i International Stem Cell Corporation mot Comptroller General of Patents, Designs and Trade Marks (in English: “Patentability of Pluripotent Stem Cells After the Court of Justice of the European Union’s Ruling in International Stem Cell Corporation v. Comptroller General of Patents, Designs and Trade Marks”) Mansnerus, J. & Jansson, T., p. 1-8”
–Tidskrift utgiven av Juridiska föreningen i Finland. 4/2015
“Patentering av stamcellsuppfinningar efter Brüstle mot Greenpeace (in English:”Patentability of Stem Cell Inventions After Brüstle v. Greenpeace”) Mansnerus, J. & Jansson, T.,p 56-82”
–Tidskrift utgiven av Juridiska föreningen i Finland 1/2015
“Erilaistuneiden solujen uudelleenohjelmointikantasoluiksi – biolääketieteellisiä, eettisiä ja oikeudellisia kysymyksiä (in English: Reprogramming Differentiated Cells into Stem Cells – Biomedical, Ethical, and Legal Issues) Mansnerus, J., 2012, Biolääketiede, tutkimus ja oikeus . Lahti, R. (ed.). Helsingin yliopisto Oikeustieteellinen tiedekunta, Vol. 2012. p. 119–148”
– Forum Iuris 2021
“PhD thesis supervisor and lecturer in various health law courses and seminars”
– University of Helsinki, 2020–
“Lecturer in “Intellectual Property Law course (immateriaalioikeus/immaterialrätt).”
– University of Helsinki, 2018–
“Lecturer in “Consumer Law course (kuluttajaoikeus/konsumenträtt).”
– University of Helsinki, 2018–
English
Finnish
Swedish
News
